A61P 43 - Drugs for specific purposes, not provided for in groups

Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
12/2011
12/29/2011	WO2011162267A1 Novel thiophenecarboxamide derivatives and use thereof as medicine
12/29/2011	WO2011162222A1 Novel crystalline forms of 4,4'-[4-fluoro-7-({4-[4-(3-fluoro-2-methylphenyl)butoxy]phenyl}ethynyl)-2-methyl-1h-indole-1,3-diyl]dibutanoic acid, 4,4'-[2-methyl-7-({4-[4-(pentafluorophenyl)butoxy]phenyl}ethynyl)-1h-indole-1,3-diyl]dibutanoic acid, and 4,4'-[4-fluoro-2-methyl-7-({4-[4-(2,3,4,6-tetrafluorophenyl)butoxy]phenyl}ethynyl)-1h-indole-1,3-diyl]dibutanoic acid
12/29/2011	WO2011162115A1 PHARMACEUTICAL COMPOSITION UTILIZING PANCREATIC β CELL PROLIFERATION FACTOR
12/29/2011	WO2011161964A1 Agent for improving insulin resistance with acat inhibitor as active component
12/29/2011	WO2011160826A1 Botulinum toxin therapy
12/29/2011	WO2011160259A1 Use of n-carbamoyl glutamic acid, salts or esters thereof in manufacture of health care products for protecting liver or promoting muscle growth
12/29/2011	WO2011160252A1 Organic acid salts of penehyclidine optical isomer
12/29/2011	WO2011089168A3 Special composition for the use thereof as a drug
12/29/2011	US20110319868 Methods, substrates, and systems useful for cell seeding of medical grafts
12/29/2011	US20110319790 Pharmaceutical composition and system for permeabilizing fetal membranes
12/29/2011	US20110319479 Polypeptides and polynucleotides encoding same and use thereof in the treatment of medical conditions associated with ischemia
12/29/2011	US20110319465 Estrogen receptor modulators and uses thereof
12/29/2011	US20110319358 Glucosamine and method of making glucosamine from microbial biomass
12/29/2011	US20110319346 Electrostatic protein/glucosinolate complexes
12/29/2011	US20110319328 Bone morphogenetic protein compositions
12/29/2011	US20110319318 Covalent milk protein/isothiocyanate complexes
12/29/2011	US20110318832 Human Telomerase Catalytic Subunit
12/29/2011	US20110318419 Graft materials containing bioactive substances, and methods for their manufacture
12/29/2011	US20110318362 Novel card proteins involved in cell death regulation
12/29/2011	US20110318355 Mutant proteins of the f protein of piv-5 and piv-2
12/29/2011	US20110318340 Deglycosylated antibodies
12/29/2011	US20110318333 Novel non-toxic composition and method of using such for treating a degenerative or an immune system-related disease
12/29/2011	US20110318327 Treatment of sanfilippo syndrome type b
12/29/2011	US20110318321 Controlled release pharmaceutical or food formulation and process for its preparation
12/29/2011	US20110318318 Anti-apoptotic fusion proteins
12/29/2011	CA2803913A1 Tumor growth controlling method targeting galactosylceramide expression factor-1
12/29/2011	CA2803159A1 New crystalline forms of 4,4'-[4-fluoro-7-({4-[4-(3-fluoro-2-methylphenyl)butoxy]phenyl}ethynyl)-2-methyl-1h-indole-1,3-diyl]dibutanoic acid, 4,4'-[2-methyl-7-({4-[4-(pentafluorophenyl)butoxy]phenyl}ethynyl)-1h-indole-1,3-diyl]dibutanoic acid, and 4,4'-[4-fluoro-2-methyl-7-({4-[4-(2,3,4,6-tetrafluorophenyl)butoxy]phenyl}ethynyl)-1h-indole-1,3-diyl]dibutano
12/28/2011	EP2399927A1 Novel compound, phosphorylation inhibitor, insulin resistance improving agent, agent to prevent or to treat diabetes, and screening method
12/28/2011	EP2399921A1 Heterocyclic compound and use thereof
12/28/2011	EP2399917A1 Novel compounds comprising a 3-(5-alkoxypyrimidin-2-yl) pyrimidin-4(3h)-one structure and drugs that comprise same
12/28/2011	EP2399903A1 Ccr9 inhibitors and methods of use thereof
12/28/2011	EP2399601A1 Botulinum toxin therapy
12/28/2011	EP2399597A1 Disinfectant making air fresh and preparation method and use thereof
12/28/2011	EP2399588A1 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
12/28/2011	EP2398781A1 1,4-benzodiazepin-2-on derivatives
12/28/2011	EP2398472A2 Methods and preparations for protecting critically ill patients with a polyamine (e.g. spermine, spermidine)
12/28/2011	EP1971341B1 Use of morpholino compounds for the treatment of halitosis
12/28/2011	EP1443920B1 Preparation for improving the action of receptors
12/28/2011	EP1411918B1 Methods to mobilize progenitor/stem cells
12/28/2011	EP1316315B1 Serum thymic factor for use in the treatment of oxidative stress in allergy
12/28/2011	CN102300588A 低聚物-吩噻嗪缀合物 Oligomer - phenothiazine conjugate
12/28/2011	CN102300577A 羧甲基精氨酸生成抑制剂和胶原变性抑制剂 Carboxymethyl-arginine production inhibitors and inhibitors of collagen denaturation
12/28/2011	CN102295643A 2-(吡啶-2-基氨基)-吡啶并[2,3-d]嘧啶-7-酮 2- (pyridin-2-ylamino) - pyrido [2,3-d] pyrimidin-7-one
12/28/2011	CN102294002A 一种治疗奶牛外感型自汗的中药组合物 A method of treating cows exogenous type of medicine spontaneous composition
12/28/2011	CN102293994A 一种治疗甲状腺炎的药物及其制备方法 An thyroiditis and preparation method of treatment
12/28/2011	CN102293907A 一种治疗役牛风劳的中药组合物及其制备方法 A method of treating cattle wind labor medicine service composition and its preparation method
12/28/2011	CN102293835A 一种治疗奶牛体虚型自汗的中药组合物 A method of treating cows physically weak spontaneous type of traditional Chinese medicine composition
12/28/2011	CN102293753A 辅酶q10纳米混悬剂冻干组合物及其制备方法和应用 Coenzyme q10 nanosuspension lyophilized composition and preparation method and application
12/28/2011	CN101816775B 一种治疗奔豚的中药组合物及其制备方法 An Bentun Chinese medicine composition and preparation method of treatment
12/28/2011	CN101693015B 一种辅酶a药物冻干制剂及其制备方法 A lyophilized preparation of a drug and its preparation method coenzyme
12/28/2011	CN101550103B 1,2,3,4-四氢异喹啉衍生物及其合成方法和用途 1,2,3,4-tetrahydroisoquinoline derivatives and synthetic method and use
12/27/2011	US8086277 Transmitter of wireless microphone, receiver for wireless microphone, portable information communication device, and wireless microphone communication system
12/27/2011	US8084645 4-phenylamino-benzaldoxime derivatives and uses thereof as mitogen-activated protein kinase kinase (MEK) inhibitors
12/27/2011	US8084465 Derivatives of pryidone and use thereof
12/27/2011	US8084447 Pharmaceutical composition comprising gabapentin or an analogue thereof and an α-aminoamide and its analgesic use
12/27/2011	US8084425 Dopaminergic neuronal survival-promoting factors and uses thereof
12/27/2011	US8084413 Urocortin-III and uses thereof
12/27/2011	US8084233 Nucleic acids encoding anti-IL-12 antibody
12/27/2011	US8084049 Complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives
12/27/2011	US8084040 Use of bacterium for manufacture of a vaccine
12/22/2011	WO2011159781A2 Bitter taste modulators
12/22/2011	WO2011158933A1 Agent for treating renal fibrosis
12/22/2011	WO2011158880A1 Crystal of amide compound
12/22/2011	WO2011158833A1 Agent for treating hcv infection
12/22/2011	WO2011158806A1 Process for production of hematopoietic stem cell
12/22/2011	WO2011158689A1 Agent for reducing acetaldehyde in oral cavity
12/22/2011	US20110313540 in or relating to growing cells
12/22/2011	US20110313041 Food supplements on the basis of pantothenic acid
12/22/2011	US20110313029 Diagnostic and therapeutic uses of gnptab, gnptg, and nagpa in stuttering
12/22/2011	US20110313005 Topically applicable pharmaceutical preparation
12/22/2011	US20110313004 Deuterated pyridinones
12/22/2011	US20110313000 Ccr9 inhibitors and methods of use thereof
12/22/2011	US20110312982 Cancer Treatment Method
12/22/2011	US20110312974 Heteroaryl antagonists of prostaglandin d2 receptors
12/22/2011	US20110312935 1H-Benz Imidazole-5-Carboxamides As Anti-Inflammatory Agents
12/22/2011	US20110312920 Cavity induced allosteric modification of intermolecular interactions and methods of identifying compounds that effect the same
12/22/2011	US20110312889 Sustained release of microcrystalline peptide suspensions
12/22/2011	US20110312886 TGF-ß AND METHODS OF TREATING OCULAR AND OTHER DISEASES
12/22/2011	US20110312872 Norrin in the treatment of diseases associated with an increased tgf-beta activity
12/22/2011	US20110311610 Temperature reducing, healing wound dressing
12/22/2011	US20110311556 Anti-rhesus d monoclonal antibody
12/22/2011	US20110311541 Mutant proteins of the f protein of piv-5 and piv-2
12/22/2011	US20110311533 Regulation of protein level
12/22/2011	US20110311482 Hepatitis C Virus Inhibitors
12/22/2011	US20110311444 Imaging diagnostic agent and extracorporeal diagnostic agent for incurable neurological diseases
12/22/2011	US20110311442 Direct cellular energy delivery system
12/22/2011	CA2802483A1 Crystal of amide compound
12/22/2011	CA2802477A1 Agent for treating hcv infection
12/22/2011	CA2802414A1 Agent for treating renal fibrosis
12/21/2011	EP2397481A1 Inhibitor of casein kinase 1delta and casein kinase 1epsilon
12/21/2011	EP2397480A1 Diazepinedione derivative
12/21/2011	EP2397479A1 Hetero ring derivative
12/21/2011	EP2397476A2 Indole derivative having PGD2 receptor antagonist activity
12/21/2011	EP2397157A1 Brain tumor stem cell differentiation promoter, and therapeutic agent for brain tumor
12/21/2011	EP2397137A1 Use of inverse antagonists and/or agonists of cb1 receptors for preparing drugs to increase motor neurone excitability
12/21/2011	EP2397127A1 Use of creatine or creatine compounds for skin preservation
12/21/2011	EP2396298A1 Novel substituted indanes, method for the production thereof, and use thereof as drugs
12/21/2011	EP2396040A1 Use of buffers for radionuclide complexation
12/21/2011	EP2395990A1 Material and methods for treating developmental disorders including comorbid and idiopathic autism
12/21/2011	EP2077111B1 Antidepressant agent

1 ... 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 ... 1564